Abstract

BackgroundAntibiotic resistance has become an increasingly serious problem in the past decades. As an alternative choice, antimicrobial peptides (AMPs) have attracted lots of attention. To identify new AMPs, machine learning methods have been commonly used. More recently, some deep learning methods have also been applied to this problem.ResultsIn this paper, we designed a deep learning model to identify AMP sequences. We employed the embedding layer and the multi-scale convolutional network in our model. The multi-scale convolutional network, which contains multiple convolutional layers of varying filter lengths, could utilize all latent features captured by the multiple convolutional layers. To further improve the performance, we also incorporated additional information into the designed model and proposed a fusion model. Results showed that our model outperforms the state-of-the-art models on two AMP datasets and the Antimicrobial Peptide Database (APD)3 benchmark dataset. The fusion model also outperforms the state-of-the-art model on an anti-inflammatory peptides (AIPs) dataset at the accuracy.ConclusionsMulti-scale convolutional network is a novel addition to existing deep neural network (DNN) models. The proposed DNN model and the modified fusion model outperform the state-of-the-art models for new AMP discovery. The source code and data are available at https://github.com/zhanglabNKU/APIN.

Highlights

  • In recent years, antimicrobial peptides (AMPs) have attracted lots of attention due to the well-known antibiotic resistance problem

  • Because of the ability of the multi-scale convolutional network to capture multi-scale motifs, the proposed model outperforms the state-of-the-art deep neural network (DNN) model [23] in AMP identification

  • The first dataset we used is made by Veltri et al (2018) [23], containing 1778 AMPs constructed from the Antimicrobial Peptide Database (APD) vr.3 database [30] and 1778 non-AMPs constructed from UniProt [31]

Read more

Summary

Introduction

Antimicrobial peptides (AMPs) have attracted lots of attention due to the well-known antibiotic resistance problem. AMPs have antimicrobial activity under specific circumstances since the difference between microbial and host cells in biochemical and biophysical provides a basis for selective toxicity of AMPs [2]. AMPs exhibit many advantages including fast killing, low toxicity, and broad range of activity [3]. AMPs show a lower likelihood for antimicrobial resistance compared to many antibiotics [4]. Antibiotic resistance has become an increasingly serious problem in the past decades. Antimicrobial peptides (AMPs) have attracted lots of attention. To identify new AMPs, machine learning methods have been commonly used. Some deep learning methods have been applied to this problem

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call